Omada Health Inc（OMDA）資訊與事件OMDAOmada Health Inc

Company Raises FY26 EBITDA Outlook to $21M-$27M

Consensus $327.97M. Raises FY26 adjusted EBITDA view to $21M-$27M from $14M-$20M. "At the midpoint, our raised full-year outlook represents approximately 30% year-over-year revenue growth and a fourfold increase in adjusted EBITDA, reflecting our extraordinary second-quarter performance and our path of sustainable profitability," said CFO Steve Cook.

Omada Reports Q2 Revenue of $88M, Exceeds Expectations

Reports Q2 revenue $88M, consensus $80.06M. Reports Q2 total members increased 45% year-over-year, reflecting continued demand across the company's integrated cardiometabolic care platform. "Our outstanding second quarter reflects the strength of our strategy, the momentum we've built across the business, and the exceptional team driving Omada forward," said CEO Sean Duffy.

Omada Health Reports Q1 Revenue of $78.05M

Reports Q1 revenue $78.05M, consensus $74.09M. "Surpassing one million Total Members is a milestone that reflects the durable growth and operating leverage we've built over 15 years of earning trust with many of the nation's leading employers, health plans, and PBMs," said Sean Duffy, co-founder and CEO of Omada Health. "We're proud to now have relationships with all three of the nation's leading PBMs - including our newest collaboration with Optum Rx - giving us broad ability to meet employers wherever they are on their GLP-1 and cardiometabolic journey, and a platform we believe positions us to successfully meet our market opportunity in the years ahead."